116 related articles for article (PubMed ID: 20033802)
1. Evidence for neuroendocrine function of a unique splicing form of TCF7L2 in human brain, islets and gut.
Prokunina-Olsson L; Hall JL
Diabetologia; 2010 Apr; 53(4):712-6. PubMed ID: 20033802
[TBL] [Abstract][Full Text] [Related]
2. Unique splicing pattern of the TCF7L2 gene in human pancreatic islets.
Osmark P; Hansson O; Jonsson A; Rönn T; Groop L; Renström E
Diabetologia; 2009 May; 52(5):850-4. PubMed ID: 19247628
[TBL] [Abstract][Full Text] [Related]
3. Tissue-specific alternative splicing of TCF7L2.
Prokunina-Olsson L; Welch C; Hansson O; Adhikari N; Scott LJ; Usher N; Tong M; Sprau A; Swift A; Bonnycastle LL; Erdos MR; He Z; Saxena R; Harmon B; Kotova O; Hoffman EP; Altshuler D; Groop L; Boehnke M; Collins FS; Hall JL
Hum Mol Genet; 2009 Oct; 18(20):3795-804. PubMed ID: 19602480
[TBL] [Abstract][Full Text] [Related]
4. Alternative splicing of TCF7L2 gene in omental and subcutaneous adipose tissue and risk of type 2 diabetes.
Prokunina-Olsson L; Kaplan LM; Schadt EE; Collins FS
PLoS One; 2009 Sep; 4(9):e7231. PubMed ID: 19789636
[TBL] [Abstract][Full Text] [Related]
5. Genotype and tissue-specific effects on alternative splicing of the transcription factor 7-like 2 gene in humans.
Mondal AK; Das SK; Baldini G; Chu WS; Sharma NK; Hackney OG; Zhao J; Grant SF; Elbein SC
J Clin Endocrinol Metab; 2010 Mar; 95(3):1450-7. PubMed ID: 20097709
[TBL] [Abstract][Full Text] [Related]
6. An alternative polyadenylation signal in TCF7L2 generates isoforms that inhibit T cell factor/lymphoid-enhancer factor (TCF/LEF)-dependent target genes.
Locke JM; Da Silva Xavier G; Rutter GA; Harries LW
Diabetologia; 2011 Dec; 54(12):3078-82. PubMed ID: 21913056
[TBL] [Abstract][Full Text] [Related]
7. TCF7L2 in mouse pancreatic beta cells plays a crucial role in glucose homeostasis by regulating beta cell mass.
Takamoto I; Kubota N; Nakaya K; Kumagai K; Hashimoto S; Kubota T; Inoue M; Kajiwara E; Katsuyama H; Obata A; Sakurai Y; Iwamoto M; Kitamura T; Ueki K; Kadowaki T
Diabetologia; 2014 Mar; 57(3):542-53. PubMed ID: 24317852
[TBL] [Abstract][Full Text] [Related]
8. Regulation of wingless-type MMTV integration site family (WNT) signalling in pancreatic islets from wild-type and obese mice.
Krützfeldt J; Stoffel M
Diabetologia; 2010 Jan; 53(1):123-7. PubMed ID: 19898815
[TBL] [Abstract][Full Text] [Related]
9. In vitro modulation of TCF7L2 gene expression in human pancreatic cells.
Khalooghi K; Hashemi S; Mehraban N; Amiri P; Bazzaz JT; Larijani B; Amoli MM
Mol Biol Rep; 2009 Nov; 36(8):2329-32. PubMed ID: 19156536
[TBL] [Abstract][Full Text] [Related]
10. Insulin treatment and high-fat diet feeding reduces the expression of three Tcf genes in rodent pancreas.
Columbus J; Chiang Y; Shao W; Zhang N; Wang D; Gaisano HY; Wang Q; Irwin DM; Jin T
J Endocrinol; 2010 Oct; 207(1):77-86. PubMed ID: 20675304
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes.
Lyssenko V; Lupi R; Marchetti P; Del Guerra S; Orho-Melander M; Almgren P; Sjögren M; Ling C; Eriksson KF; Lethagen AL; Mancarella R; Berglund G; Tuomi T; Nilsson P; Del Prato S; Groop L
J Clin Invest; 2007 Aug; 117(8):2155-63. PubMed ID: 17671651
[TBL] [Abstract][Full Text] [Related]
12. Association of variants of the TCF7L2 gene with increases in the risk of type 2 diabetes and the proinsulin:insulin ratio in the Spanish population.
González-Sánchez JL; Martínez-Larrad MT; Zabena C; Pérez-Barba M; Serrano-Ríos M
Diabetologia; 2008 Nov; 51(11):1993-7. PubMed ID: 18712344
[TBL] [Abstract][Full Text] [Related]
13. Transcription factor 7-like 2 regulates beta-cell survival and function in human pancreatic islets.
Shu L; Sauter NS; Schulthess FT; Matveyenko AV; Oberholzer J; Maedler K
Diabetes; 2008 Mar; 57(3):645-53. PubMed ID: 18071026
[TBL] [Abstract][Full Text] [Related]
14. Molecular function of TCF7L2: Consequences of TCF7L2 splicing for molecular function and risk for type 2 diabetes.
Hansson O; Zhou Y; Renström E; Osmark P
Curr Diab Rep; 2010 Dec; 10(6):444-51. PubMed ID: 20878273
[TBL] [Abstract][Full Text] [Related]
15. Prime suspect: the TCF7L2 gene and type 2 diabetes risk.
Hattersley AT
J Clin Invest; 2007 Aug; 117(8):2077-9. PubMed ID: 17671643
[TBL] [Abstract][Full Text] [Related]
16. TCF7L2 splice variants have distinct effects on beta-cell turnover and function.
Le Bacquer O; Shu L; Marchand M; Neve B; Paroni F; Kerr Conte J; Pattou F; Froguel P; Maedler K
Hum Mol Genet; 2011 May; 20(10):1906-15. PubMed ID: 21357677
[TBL] [Abstract][Full Text] [Related]
17. Variants of the TCF7L2 gene are associated with beta cell dysfunction and confer an increased risk of type 2 diabetes mellitus in the ULSAM cohort of Swedish elderly men.
Dahlgren A; Zethelius B; Jensevik K; Syvänen AC; Berne C
Diabetologia; 2007 Sep; 50(9):1852. PubMed ID: 17618413
[TBL] [Abstract][Full Text] [Related]
18. No effect of cancer-associated SNP rs6983267 in the 8q24 region on co-expression of MYC and TCF7L2 in normal colon tissue.
Prokunina-Olsson L; Hall JL
Mol Cancer; 2009 Nov; 8():96. PubMed ID: 19895682
[TBL] [Abstract][Full Text] [Related]
19. Wnt signaling in pancreatic islets.
Liu Z; Habener JF
Adv Exp Med Biol; 2010; 654():391-419. PubMed ID: 20217507
[TBL] [Abstract][Full Text] [Related]
20. Variants of transcription factor 7-like 2 (TCF7L2) gene predict conversion to type 2 diabetes in the Finnish Diabetes Prevention Study and are associated with impaired glucose regulation and impaired insulin secretion.
Wang J; Kuusisto J; Vänttinen M; Kuulasmaa T; Lindström J; Tuomilehto J; Uusitupa M; Laakso M
Diabetologia; 2007 Jun; 50(6):1192-200. PubMed ID: 17437080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
